• Publications
  • Influence
Th17 and IL-17 immunity in chronic hepatitis C infection.
Novel intriguing data indicate that Th17 boost could be associated with spontaneous HCV clearance and could play a dual role (both beneficial and harmful) and that an unbalance of regulating factors rather than the lymphocyte itself could tip the Th17 immune response one way or another. Expand
Serum endocan levels are increased in patients with inflammatory bowel disease.
There is a potential role for endocan in future biomarker studies in IBD patients, and levels were significantly higher in the IBD group as compared to both healthy controls and cancer patients. Expand
Candidate proteomic biomarkers for non-alcoholic fatty liver disease (steatosis and non-alcoholic steatohepatitis) discovered with mass-spectrometry: a systematic review
Critically review proteomic studies that used mass spectrometry techniques and summarize relevant proteomic NAFLD candidate biomarkers to identify some of the biomarkers identified that have already been extensively studied regarding their diagnostic and prognostic capacity. Expand
Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study
Endocan is expressed by endothelial cells and associated with endothelial dysfunction; therefore it could be a potential biomarker for Ssc patients. Expand
IL-17, IL-6 and IFN-γ in systemic sclerosis patients
Th17 and Th1 cell responses are active in Ssc patients as their cytokines associated with higher disease activity scores and pulmonary manifestations, including higher serum IFN-γ levels associated with pulmonary hypertension. Expand
Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review
Research in SSc proteomic biomarkers should focus on biomarker validation, as there are valuable mass-spectrometry proteomics studies in the literature. Expand
Association of anti phosphatidyl ethanolamine antibodies and low complement levels in systemic sclerosis patients – results of a cross-sectional study
IgM anti phosphatidyl ethanolamine antibodies seem to be more frequent and the dominant antiphospholipid antibody type in the group recruited from the Romanian Ssc population, and these antibodies were associated with low complement levels in Ssc patients. Expand
Circulating Reticulocalbin 1 and Reticulocalbin 3 in Systemic Sclerosis Patients: Results of a Case Control Study.
RCN1 was associated with disease activity score and could be used as a stratification biomarker for Ssc patients, as patients with high RCN1 shared a particular disease pattern. Expand
Introduction. Recent meta-analyses of population-based studies show considerable heterogeneity in the prevalence of perceived and confi rmed allergic reactions, as well as sensitization to cow milkExpand